About
Zenicor Medical Systems AB is a Swedish medtech company founded in 2003, focused on the early diagnosis of cardiac arrhythmias, particularly atrial fibrillation, and stroke prevention. Based in Stockholm, Zenicor is recognized as a leader in remote cardiology diagnostics and arrhythmia detection across Europe. The company develops the Zenicor-ECG system, which includes a handheld ECG device that allows patients to record their electrocardiography (ECG) data over extended periods. This data is transmitted via 4G/5G to a central database, accessible to healthcare providers through the Zenicor View platform. Zenicor also offers continuous ECG monitoring options, tailored ECG interpretation services, and remote interpretation assistance, all designed to enhance arrhythmia diagnostics. Zenicor collaborates with healthcare providers and research institutions, including Karolinska Institutet, to refine its solutions. Its technology has been validated in various scientific studies and is used in over 350 clinics across Northern Europe, Germany, Austria, Switzerland, and Great Britain, serving hospitals and healthcare providers focused on cardiology and stroke prevention. The company is certified under the European Medical Device Regulation (MDR) since January 2023.
Technologies
Keywords
Company Information
-
Employees 18
-
Founded 2003
Location
8 Saltmaetargatan, Stockholm, Stockholm County, Sweden, 113 59
